A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine

NCT00000628 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: L-697,661
DRUG: Zidovudine

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]